Free Shipping Available. Buy Doctor who serie on eBay. Money Back Guarantee!
Search results
A large supporter of clinical research, Dr. Brubaker has been a principal investigator for over 20 clinical studies, including multiple phase III trials that led to FDA approval of new glaucoma devices, medications and implants. Dr. Brubaker has an extensive list of publications, book chapters, presentations, and awards for his research.
He also is an outdoor sports enthusiast and loves backpacking, camping, skiing, and mountain biking. Jacob W. Brubaker, MD is a glaucoma specialist in Sacramento CA with advanced training in glaucoma treatments. Call 916-915-0300 for details.
Dr. Jacob W. Brubaker is an ophthalmologist in Sacramento, California and is affiliated with Mercy General Hospital.He received his medical degree from McGill University Faculty of Medicine and ...
- Sacramento, CA
- (916) 453-4545
Castle Connolly. Top Doctors 2024. Jacob Brubaker, MD, Patricia Sierra, MD & Samuel Lee, MD – Top Docs in 2022. Sacramento Eye Consultants – Sacramento Top Docs since 1994. Patricia Sierra, MD, Samuel Lee, MD, & Peter Wu, MD - Best LASIK Surgeons in 2023. Jacob Brubaker, MD, Patricia Sierra, MD & Samuel Lee, MD – Top Docs in 2021.
Focused on LASIK Eye Surgery, minimally invasive glaucoma and cataract surgeries in Sacramento and Lincoln. If you are looking for an eye surgeon in Sacramento, consider Jacob Brubaker, Samuel Lee, Xiongfei Liu, Patricia Sierra, or Peter Wu. Our surgeons have extensive experience enhancing vision not only with LASIK, but also for those in need ...
Dr. Jacob W. Brubaker, M.D., is an Ophthalmologist practicing in multiple locations, including Sacramento, CA. See Doctor 's full profile and credentials.
People also ask
Who is Dr. Jacob Brubaker?
What is Dr. Brubaker currently doing?
Why did Dr Brubaker choose glaucoma?
Apr 8, 2018 · Jacob Brubaker, MD. e. jbrubaker@saceye.com. This article is based on a poster presented by Dr. Brubaker at the 2018 American Glaucoma Society meeting. Dr. Brubaker is a consultant to and receives research grant funding from Aerie Pharmaceuticals.